Robbins Arroyo LLP Is Investigating the Officers and Directors of Amyris, Inc. (AMRS) on Behalf of Shareholders
Robbins Arroyo LLP is investigating whether certain officers and directors of Amyris, Inc. (NasdaqGS: AMRS) violated federal securities laws by issuing materially false and misleading statements regarding the company’s business and operations. Amyris provides various alternatives to a range of petroleum-sourced products worldwide.
Amyris Unable to Recognize $10 Million in Revenue
On April 17, 2017, Amyris filed a Form 10-K with the U.S. Securities and Exchange Commission reporting revenues of $67.2 million for fiscal year 2016 – a decrease of $10 million from the revenue figures it disclosed on March 2, 2017 and April 3, 2017. The decline in revenue was attributed to Amyris’ decision in the first quarter of 2017 to take an equity stake in one of Blue California’s affiliates instead of taking a cash payment as required under the license agreement. Over the course of the following three trading days, Amyris’ stock fell $0.19 per share, or approximately 27%, to close at $0.51 per share on April 20, 2017.
Amyris Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leonid Kandinov at (800) 350-6003, or you can complete the form below and we will contact you directly.